BRISBANE, Australia – With the recent launch of its O2Vent sleep apnea device, Oventus hopes to change the way sleep disorders are treated. “O2Vent is unique because the patented airway design allows patients to breathe through a separate airway, which has never been done before,” said Dr. Chris Hart, Oventus founder and clinical director, in a statement. The O2Vent uses 3D printing technologies and is customized for each patient from medical-grade titanium. The device, cleared by the U.S. Food and Drug Administration, provides relief for snoring and obstructive sleep apnea through a unique, separate airway that avoids multiple sites of obstruction, including the nose, the soft palate and the tongue. A 2016 clinical study showed Oventus’ first generation product, the O2Vent Mono, either eliminated or significantly reduced snoring in 100% of patients. A second clinical trial is currently underway.
You are here: / / Oventus launches sleep apnea device